EVERSANA is proud to be a diamond sponsor of World Orphan Drug Congress USA 2025 April 22-24 in Boston, MA.
The World Orphan Drug Congress convenes top pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers. This conference provides a forum to discuss and advance orphan drug development and enhance access to life-saving therapies for individuals living with a rare disease.
Join us to engage with top pharma companies and gain insights from a diverse lineup of speakers addressing the most pressing challenges and opportunities in the industry, including the presentation and panel below featuring EVERSANA experts. Learn More About WODC.
WODC EVERSANA Presentation
Presentation Title: Validation of a Machine Learning Predictive Model for the Identification of APDS Patients
Date and Time: April 24 at 11 A.M.
Presenters:
Dr. Pierantonio Russo, Corporate Chief Medical Officer
Dr. Ramaa Nathan, Vice President, Data Science and Real World Evidence
Description: Dr. Russo and Dr. Nathan will present predictive modeling techniques to identify patients with rare diseases lacking specific ICD codes in administrative claims data. Using Activated PI3K Delta Syndrome (APDS) as a case study, they will showcase how rule-based and machine learning models detected probable APDS patients and were validated against newly assigned ICD-10 codes.
They will discuss key findings, including the model’s accuracy and potential to transform patient identification and healthcare utilization analysis. Don’t miss this opportunity to explore cutting-edge advancements in predictive analytics and their impact on rare disease research.
WODC Panel
Presentation Title: Navigating the Intersection of Technology and Personalized Care for Rare Disease Patients
EVERSANA Panelists: Matt Baniak and Lindsay Reel + other industry experts
Date and Time: April 23 at 12:35 P.M.
Description: While AI and machine learning are revolutionizing healthcare, rare disease patients often need more personalized, one-on-one support. This panel brings together industry experts to delve into the nuanced balance between cutting-edge technology and compassionate, individualized care.
Join us to explore how patient support programs can determine the right moments to employ advanced technological solutions and when to prioritize human interaction, ensuring the best outcomes for rare disease patients.